The Proteasome-Guided Haem Signalling Axis in T Cell Exhaustion
This research identifies a novel biological pathway where mitochondrial dysfunction triggers T cell exhaustion, a state of reduced effectiveness that hinders the body's ability to fight cancer. Scientists discovered that when mitochondria lose their integrity, cells increase proteasome activity to degrade damaged proteins, an action that inadvertently releases regulatory haem. This excess haem enters the nucleus and disrupts BACH2, a critical transcription factor responsible for maintaining the "stem-like" regenerative capacity of immune cells. The study demonstrates that high proteasome gene signatures in patients receiving CAR-T cell therapy correlate with poor clinical outcomes and rapid cancer relapse. To combat this, researchers found that using bortezomib, a proteasome inhibitor, during the manufacturing of CAR-T cells prevents exhaustion and significantly boosts their anti-tumour efficacy. These findings suggest that targeting the proteasome-haem axis offers a promising strategy to enhance the durability and success of adoptive cellular immunotherapies.
Powered by Firstory Hosting (https://firstory.me/zh)
28 Feb 2026
Whole-organ and whole-body 3D atlases enable cellome-wide profiling
Researchers have developed the CUBIC Organ and Body Atlas, a high-resolution 3D framework designed for single-cell analysis across entire mammalian organisms. This resource utilizes advanced tissue clearing and a specialized light-sheet microscopy system called exMOVIE to achieve rapid, cellular-level imaging of intact organs and neonatal bodies. By converting these massive datasets into point cloud coordinates, the team enables precise quantification of cell numbers, densities, and spatial distributions in healthy and diseased states. The study demonstrates the atlas’s utility by mapping pathological changes in kidney injury and lung inflammation, as well as tracking systemic immune cell recruitment. This open-source platform serves as a "white map" for the scientific community, allowing for the integration of multimodal biological data into a standardized spatial context.
Powered by Firstory Hosting (https://firstory.me/zh)
20 Feb 2026
GLP-1 Receptor Agonists and the Cardiovascular System
This review from The Journal of Clinical Investigation examines the extensive impact of GLP-1 receptor agonists on the cardiovascular system. Preclinical research demonstrates that these therapies provide direct vascular protection by reducing inflammation and stabilizing atherosclerotic plaques, often independently of weight loss or glucose levels. In clinical settings, large-scale trials have confirmed that long-acting versions of these drugs significantly lower the risk of major adverse cardiovascular events, such as heart attacks and strokes. The text also highlights the emerging benefits for patients with heart failure, particularly those with the obesity-related preserved ejection fraction phenotype. Ultimately, the authors position these medications as a foundational treatment for reducing cardiovascular risk in individuals with type 2 diabetes, kidney disease, or obesity. This comprehensive overview bridges the gap between molecular mechanisms and real-world therapeutic outcomes in modern medicine.
Powered by Firstory Hosting (https://firstory.me/zh)
19 Feb 2026
ILF3 Mediates Transcriptional Adaptation via mRNA Decay Intermediates
This Science paper explores transcriptional adaptation, a biological resilience mechanism where the breakdown of mutated messenger RNA triggers the increased expression of related healthy genes. Investigators identified the RNA-binding protein ILF3 as a critical bridge that connects cytoplasmic decay to the activation of genes within the nucleus. By utilizing specialized tiling oligonucleotide screens, the team discovered specific mRNA fragments that act as triggers for gene up-regulation through homology-mediated base pairing with antisense transcripts. These trigger sequences were found to be effective not only for compensating with similar genes but also for self-activating the primary gene, which could help address human genetic disorders caused by haploinsufficiency. The findings suggest that programmable oligonucleotides can be specifically designed to mimic this natural pathway to therapeutically enhance gene expression. Ultimately, this work provides a detailed molecular framework for how cells maintain genetic robustness despite deleterious mutations.
Powered by Firstory Hosting (https://firstory.me/zh)
13 Feb 2026
Gemini for Google Workspace Prompting Guide 101
This guide details how to use Gemini for Google Workspace to increase productivity. Effective prompts should include Persona, Task, Context, and Format. The AI assists with writing, data organization, and image creation while maintaining privacy and security across all apps.
Powered by Firstory Hosting (https://firstory.me/zh)
7 Feb 2026
Oral PCSK9 Inhibition with Enlicitide for LDL Cholesterol Reduction
The CORALreef Lipids trial found that enlicitide, an oral PCSK9 inhibitor, significantly reduces LDL cholesterol by over 55% compared to placebo. Treatment also improved apolipoprotein B and lipoprotein(a) levels. The drug was well-tolerated with safety results similar to placebo.
Powered by Firstory Hosting (https://firstory.me/zh)
4 Feb 2026
HPCS: A Dynamic Hub for Lung Cancer Growth and Resistance
Cancer plasticity drives tumor progression and treatment resistance. Research identifies a high-plasticity cell state (HPCS) in lung adenocarcinoma that enables diverse cellular transitions. Targeting the HPCS or its molecular programs may improve clinical cancer management.
Powered by Firstory Hosting (https://firstory.me/zh)
Lantz et al. reveal that neonatal heart regeneration relies on macrophages using the MERTK receptor to engulf dying cells, stimulating thromboxane A2 (TXA2) production. TXA2 activates the TP receptor on cardiomyocytes to induce proliferation via YAP signaling, an immune-metabolic pathway necessary for regeneration that is absent in adults.
Powered by Firstory Hosting (https://firstory.me/zh)
2 Feb 2026
Human longevity is 50% determined by your genome
Let's talk about a recent Science paper showing that our life span is decided 50% by our genome.
Powered by Firstory Hosting (https://firstory.me/zh)
Contact Let's talk science
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Let's talk science?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
